[1]衡欣 陈悦.增生型糖尿病视网膜病变患者血清中转化生长因子-β1和结缔组织生长因子水平的变化及意义[J].眼科新进展,2013,33(4):000-363-365.
点击复制

增生型糖尿病视网膜病变患者血清中转化生长因子-β1和结缔组织生长因子水平的变化及意义
分享到:

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
33卷
期数:
2013年4期
页码:
000-363-365
栏目:
OA
出版日期:
2013-04-05

文章信息/Info

作者:
衡欣 陈悦
郑州大学第一附属医院眼科
关键词:
增生型糖尿病视网膜病变血清结缔组织生长因子转化生长因子-β1

相似文献/References:

[1]刘银萍 胡水旺 吴贞凤 梅立新 郎平 陆晓和.糖尿病视网膜病变患者血清β2-糖蛋白Ⅰ的表达[J].眼科新进展,2012,32(2):000.
[2]杨萍,孙书明.血清25羟维生素D3水平与2型糖尿病视网膜病变的关系研究[J].眼科新进展,2014,34(6):583.[doi:10.13389/j.cnki.rao.2014.0161]
[3]赵新荣,杨炜,邱明磊,等.玻璃体内注射雷珠单抗联合玻璃体切割术治疗严重增生型糖尿病视网膜病变[J].眼科新进展,2015,35(11):1064.[doi:10.13389/j.cnki.rao.2015.0291]
 ZHAO Xin-Rong,YANG Wei,QIU Ming-Lei,et al.Ranibizumab injection and vitrectomy for severe proliferative diabetic retinopathy[J].Recent Advances in Ophthalmology,2015,35(4):1064.[doi:10.13389/j.cnki.rao.2015.0291]
[4]刘建伟,李聪伶,于海群.雷珠单抗玻璃体内注射对增生型糖尿病视网膜病变玻璃体切割术效果的影响[J].眼科新进展,2016,36(3):265.[doi:10.13389/j.cnki.rao.2016.0071]
 LIU Jian-Wei,LI Cong-Ling,YU Hai-Qun.Effects of intravitreal injection of ranibizumab on vitrectomy for proliferative diabetic retinopathy[J].Recent Advances in Ophthalmology,2016,36(4):265.[doi:10.13389/j.cnki.rao.2016.0071]
[5]饶玉萍,徐玲娟,肖紫云,等.增生型糖尿病视网膜病变患者血浆和玻璃体中VEGF和低密度脂蛋白受体相关蛋白6的表达及其相关性[J].眼科新进展,2016,36(3):278.[doi:10.13389/j.cnki.rao.2016.0075]
 RAO Yu-Ping,XU Ling-Juan,XIAO Zi-Yun,et al.Expression and correlation of LRP6 and VEGF in plasma and vitreous of PDR patients[J].Recent Advances in Ophthalmology,2016,36(4):278.[doi:10.13389/j.cnki.rao.2016.0075]
[6]郭俊国,赵晴,王兴荣,等.六锐胶囊对葡萄膜炎大鼠血清SOD、MDA和NT-3含量的影响[J].眼科新进展,2016,36(4):334.[doi:10.13389/j.cnki.rao.2016.0090]
 GUO Jun-Guo,ZHAO Qing,WANG Xing-Rong,et al.Effects of Liurui capsules on serum SOD, MDA and NT-3 content in rats with uveitis[J].Recent Advances in Ophthalmology,2016,36(4):334.[doi:10.13389/j.cnki.rao.2016.0090]
[7]刘爱琴,王爽,张丽,等.非动脉炎性前部缺血性视神经病变患者血清孕酮水平的变化[J].眼科新进展,2016,36(5):465.[doi:10.13389/j.cnki.rao.2016.0124]
 LIU Ai-Qin,WANG Shuang,ZHANG Li,et al.Concentration of serum progesterone in patients with nonarteritic anterior ischemic optic neuropathy[J].Recent Advances in Ophthalmology,2016,36(4):465.[doi:10.13389/j.cnki.rao.2016.0124]
[8]李慧林,张国明,张福燕,等.早产儿视网膜病变血清代谢通路研究进展[J].眼科新进展,2016,36(9):881.[doi:10.13389/j.cnki.rao.2016.0237]
 LI Hui-Lin,ZHANG Guo-Ming,ZHANG Fu-Yan,et al.Research progress on serum metabonome in retinopathy of prematurity[J].Recent Advances in Ophthalmology,2016,36(4):881.[doi:10.13389/j.cnki.rao.2016.0237]
[9]孙丽丽,季拓.贝伐单抗联合全视网膜光凝治疗增生型糖尿病视网膜病变的疗效观察[J].眼科新进展,2016,36(10):949.[doi:10.13389/j.cnki.rao.2016.0254]
 SUN Li-Li,JI Tuo.Effects of bevacizumab combined with panretinal photocoagulation on proliferative diabetic retinopathy[J].Recent Advances in Ophthalmology,2016,36(4):949.[doi:10.13389/j.cnki.rao.2016.0254]
[10]韩治华,杨淑焕,郭卫民,等.TGF-β介导的Smad信号通路在增生型糖尿病视网膜病变中的作用和意义[J].眼科新进展,2016,36(10):957.[doi:10.13389/j.cnki.rao.2016.0256]
 HAN Zhi-Hua,YANG Shu-Huan,GUO Wei-Min,et al.Role and significance of TGF-β mediated Smad signaling pathways in proliferative diabetic retinopathy[J].Recent Advances in Ophthalmology,2016,36(4):957.[doi:10.13389/j.cnki.rao.2016.0256]

更新日期/Last Update: 2014-01-02